Lost and Delayed Luggage Surge in Africa, Asia & Middle East. Buenos Aires Ranks #1 Worst, Says Sostravel.com Data
18.1.2023 16:05:00 EET | Business Wire | Press release
November 25, 2022, to January 6, 2023 airlines and airports lost, damaged, or delayed an exceptional number of checked bags, with a 101% increase from a year ago, while air traffic was up only 67% YoY, with Buenos Aires, named as the worst offender.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230118005416/en/
Sostravel.com is an app for travellers to access travel technology services such as Lost Luggage Concierge. (Graphic: Business Wire)
“A lot of passengers had to break up with their bags last holiday season, as airlines and airports struggled to keep up with demand amid a combination of staffing shortages and air traffic control problems”, says Edoardo Zarghetta from Sostravel.com. “ But lost luggage is unfortunately nothing new , and the COVID-19 pandemic has only exacerbated an old problem.”
Worst Overall Destinations for Luggage
The global trend indicated by last holiday season Sostravel.com Lost Luggage Index, Europe remains the number one safest spot when it comes to baggage loss, probably due to airports and airlines being able to retain more staff, compared to the U.S. and Asia, Middle East, and Asia, where more workers were fired during the COVID-19 pandemic. The worst airports, with the most problems for luggage, as revealed by Sostravel.com data are:
- Ezeiza, Buenos Aires, Argentina
- Hariri, Beirut, Lebanon
Africa , where luggage melts in the Sun, though Buenos Aires top the charts with the worst performance.
Italy on the contrary did particularly well at staying out of trouble: the Mediterranean country continues to dominate the top of the list of Top Overall Destinations last holiday season.
Sostravel.com Lost Luggage Index
Sostravel.com first-hand proprietary data, shows the routes, airlines, and airports where bags have a better — or worse chance of reuniting with their owners.
About Sostravel.com
Sostravel.com S.p.A. is a digital tour operator with a portfolio of premium resorts, and a provider of travel-technology services and lost luggage concierge. Over 1 million users worldwide used Sostravel.com as a digital travel companion, to find deals on their trips and get information to make their journeys more enjoyable. Listed in Milan (ticker BIT:SOS) and New York (ticker SOSAF), it provide investors with exposure to global travel and digital travel technology.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230118005416/en/
Contact information
Contact Sostravel.com IR
Edoardo Zarghetta - Mob +44 7795 106913 -
Investor.relations@sostravel.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release
IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom